BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1601674)

  • 1. The evaluation of 186Re-labeled antibodies using N2S4 chelate in vitro and in vivo using tumor-bearing nude mice.
    Najafi A; Alauddin MM; Sosa A; Ma GQ; Chen DC; Epstein AL; Siegel ME
    Int J Rad Appl Instrum B; 1992 Feb; 19(2):205-12. PubMed ID: 1601674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhenium-186-mercaptoacetyltriglycine-labeled monoclonal antibody for radioimmunotherapy: in vitro assessment, in vivo kinetics and dosimetry in tumor-bearing nude mice.
    Kinuya S; Yokoyama K; Tega H; Hiramatsu T; Konishi S; Yamamoto W; Shuke N; Aburano T; Watanabe N; Takayama T; Michigishi T; Tonami N
    Jpn J Cancer Res; 1998 Aug; 89(8):870-8. PubMed ID: 9765625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A peptide-based bifunctional chelating agent for 99mTc- and 186Re-labeling of monoclonal antibodies.
    Ram S; Buchsbaum DJ
    Cancer; 1994 Feb; 73(3 Suppl):769-73. PubMed ID: 8306258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High dose rhenium-186-labeling of monoclonal antibodies for clinical application: pitfalls and solutions.
    van Gog FB; Visser GW; Stroomer JW; Roos JC; Snow GB; van Dongen GA
    Cancer; 1997 Dec; 80(12 Suppl):2360-70. PubMed ID: 9406684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and preliminary evaluation of a new chelate N2S4 for use in labeling proteins with metallic radionuclides.
    Najafi A; Alauddin MM; Siegel ME; Epstein AL
    Int J Rad Appl Instrum B; 1991; 18(2):179-85. PubMed ID: 2026493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [186Re]-labeled mouse and chimeric monoclonal antibody 323/A3: a comparison of the efficacy in experimental human ovarian cancer.
    Kievit E; van Gog FB; Schlüper HM; van Dongen GA; Pinedo HM; Boven E
    Nucl Med Biol; 1998 Jan; 25(1):37-45. PubMed ID: 9466360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the biodistribution and the efficacy of monoclonal antibody 323/A3 labeled with either 131I or 186Re in human ovarian cancer xenografts.
    Kievit E; van Gog FB; Schlüper HM; van Dongen GA; Pinedo HM; Boven E
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):813-23. PubMed ID: 9240651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Labeling of monoclonal antibodies with rhenium-186 using the MAG3 chelate for radioimmunotherapy of cancer: a technical protocol.
    Visser GW; Gerretsen M; Herscheid JD; Snow GB; van Dongen G
    J Nucl Med; 1993 Nov; 34(11):1953-63. PubMed ID: 8229241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 186Re-labeled monoclonal antibody E48 immunoglobulin G-mediated therapy of human head and neck squamous cell carcinoma xenografts.
    Gerretsen M; Visser GW; van Walsum M; Meijer CJ; Snow GB; van Dongen GA
    Cancer Res; 1993 Aug; 53(15):3524-9. PubMed ID: 8339258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with rhenium-186-labeled monoclonal antibodies for radioimmunotherapy: results of phase I trials.
    Breitz HB; Weiden PL; Vanderheyden JL; Appelbaum JW; Bjorn MJ; Fer MF; Wolf SB; Ratliff BA; Seiler CA; Foisie DC
    J Nucl Med; 1992 Jun; 33(6):1099-109. PubMed ID: 1597723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhenium-186-labeled monoclonal antibodies for radioimmunotherapy: preparation and evaluation.
    John E; Thakur ML; DeFulvio J; McDevitt MR; Damjanov I
    J Nucl Med; 1993 Feb; 34(2):260-7. PubMed ID: 8429345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 186Re-labeled antibodies to p185HER2 as HER2-targeted radioimmunopharmaceutical agents: comparison of physical and biological characteristics with 125I and 131I-labeled counterparts.
    Kotts CE; Su FM; Leddy C; Dodd T; Scates S; Shalaby MR; Wirth CM; Giltinan D; Schroff RW; Fritzberg AR; Shepard HM; Slamon DJ; Hutchins BM
    Cancer Biother Radiopharm; 1996 Apr; 11(2):133-44. PubMed ID: 10851530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies labeled with rhenium-186 using the MAG3 chelate: relationship between the number of chelated groups and biodistribution characteristics.
    van Gog FB; Visser GW; Klok R; van der Schors R; Snow GB; van Dongen GA
    J Nucl Med; 1996 Feb; 37(2):352-62. PubMed ID: 8667076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved tumor targeting of rhenium-186-labeled anti-human high-m.w. melanoma-associated antigen monoclonal antibody 763.74 following purification with anti-idiotypic monoclonal antibody MK2-23.
    Hamby CV; Chinol M; Palestro CJ; Manzo C; Ferrone S
    Int J Cancer; 1998 Nov; 78(4):486-90. PubMed ID: 9797138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete ablation of small squamous cell carcinoma xenografts with 186Re-labeled monoclonal antibody E48.
    Gerretsen M; Visser GW; Brakenhoff RH; van Walsum M; Snow GB; van Dongen GA
    Cell Biophys; 1994; 24-25():135-42. PubMed ID: 7736517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technetium-99m, rhenium-186, and rhenium-188 direct-labeled antibodies.
    Griffiths GL; Goldenberg DM; Diril H; Hansen HJ
    Cancer; 1994 Feb; 73(3 Suppl):761-8. PubMed ID: 8306257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunotherapy with 186Re-labeled monoclonal antibody to treat liver metastases of colon cancer cells in nude mice.
    Kinuya S; Yokoyama K; Kawashima A; Izumo M; Sorita T; Obata T; Watanabe N; Shuke N; Bunko H; Michigishi T; Tonami N
    Cancer Biother Radiopharm; 2002 Dec; 17(6):681-7. PubMed ID: 12537672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodistribution, pharmacokinetic, and imaging studies with 186Re-labeled NR-LU-10 whole antibody in LS174T colonic tumor-bearing mice.
    Goldrosen MH; Biddle WC; Pancook J; Bakshi S; Vanderheyden JL; Fritzberg AR; Morgan AC; Foon KA
    Cancer Res; 1990 Dec; 50(24):7973-8. PubMed ID: 2253238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioimmunotherapy for model B cell malignancies using 90Y-labeled anti-CD19 and anti-CD20 monoclonal antibodies.
    Ma D; McDevitt MR; Barendswaard E; Lai L; Curcio MJ; Pellegrini V; Brechbiel MW; Scheinberg DA
    Leukemia; 2002 Jan; 16(1):60-6. PubMed ID: 11840264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodistribution study of 188Re-labeled trisuccin-HuCC49 and trisuccin-HuCC49deltaCh2 conjugates in athymic nude mice bearing intraperitoneal colon cancer xenografts.
    Safavy A; Khazaeli MB; Safavy K; Mayo MS; Buchsbaum DJ
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):2994s-3000s. PubMed ID: 10541333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.